News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Clinical trial aims to side-step side-effects with state-of-the-art radiotherapy
A major clinical trial has shown that changing the way radiotherapy is delivered could significantly reduce the side effects associated with radiotherapy treatment for prostate cancer.
The Art of Science – Cutting edge science and captivating images
Researchers from the ICR and The Royal Marsden submitted fantastic images to this year’s ICR Science and Medical Imaging competition, with winning images by PhD student Sumana Shrestha showcasing just how captivating scientific and medical images can be.
'Genetic rewiring' by a microRNA gene drives cancer’s drug resistance
A tiny molecule of RNA – known as ‘microRNA’ – plays a key role in ‘rewiring’ cancer cells so they can resist the effects of chemotherapy, a new study reveals. The discovery opens up the possibility of creating new cancer drugs that target this microRNA molecule, rather than more conventional treatments that block the action of proteins.
Cancer vaccine could boost the effectiveness of immunotherapy
Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports.
Major investment to transform UK’s leading cancer campus
A new multimillion investment is to drive forward development of The London Cancer Hub – boosting efforts to turn it into the world’s leading life-science campus focused on overcoming cancer.
Fit to burst: How cancer-exploding viruses are changing the game
Oncolytic viruses are viruses which can burst cancer cells. In this feature, Joanne Duffy takes a look at what ICR researchers are doing in this realm, and how oncolytic viruses can help us target cancer more effectively.
MRI data can predict patient response to treatment and survival in advanced ovarian cancer
A simple test using an MRI scan can be used to predict how well people with advanced ovarian cancer will respond to treatment, according to the results of a new study.
Most innovative cancer drugs facing delays in reaching patients
Despite increasing numbers of cancer drugs being licensed, an analysis has found that highly innovative drugs took longer to reach NHS patients than more conventional treatments.
ICR research showcased in major new Science Museum gallery documenting history of medicine
The Science Museum's new £24 million medicine galleries showcases pioneering research from The Institute of Cancer Research, London, as part of its story of modern medicine.
Adding chemotherapy to radiotherapy for bladder cancer shows benefits for patients
Data from a clinical trial which assessed the benefits of adding chemotherapy alongside radiotherapy for patients with muscle invasive bladder cancer has shown that this treatment can be given without substantially impacting subsequent health related quality of life.
Cancers engaged in evolutionary arms race with immune system
Aggressive, highly mutated cancers evolve escape routes in response to immune attacks in an ‘evolutionary arms race’ between cancer and the immune system, a new study reports.
The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer
The ICR has criticised the decision by NICE not to recommend the immunotherapy, pembrolizumab, as a first-line treatment for patients with advanced head and neck cancer and is calling for an urgent reassessment of the evidence for the drug’s benefit.
